Inhibition of nitric-oxide synthase enhances antigen-induced contractions and increases release of cysteinyl-leukotrienes in guinea pig lung parenchyma: Nitric oxide as a protective factor

Journal of Pharmacology and Experimental Therapeutics

Volumn 315, Issue 1, 2005, Pages 458-465

  Larsson, Anna Karin ^a   Bäck, Magnus ^a   Hjoberg, Josephine ^a   Dahlén, Sven Erik ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

2 CYCLOPENTYL 2 [4 (2 QUINOLINYLMETHOXY)PHENYL]ACETIC ACID; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; ANTIGEN; ARGININE; HISTAMINE; INDOMETACIN; LEUKOTRIENE D4; LIPOXYGENASE INHIBITOR; N [3 (AMINOMETHYL)BENZYL]ACETAMIDINE; N(G) NITROARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; OVALBUMIN; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME INHIBITION; GUINEA PIG; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; PULMONARY ARTERY OCCLUSION;

ANIMALS; ARACHIDONATE 5-LIPOXYGENASE; CYSTEINE; DINOPROSTONE; ENZYME INHIBITORS; GUINEA PIGS; LEUKOTRIENES; LUNG; MALE; MUSCLE CONTRACTION; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROARGININE; OVALBUMIN;

EID: 25644443205     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.105.086694     Document Type: Article

References (34)

1. Alving K, Weitzberg E, and Lundberg JM (1993) Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 6:1368-1370.
2. Bäck M, Walch L, Norel X, Gascard JP, Mazmanian G, and Brink C (2002) Modulation of vascular tone and reactivity by nitric oxide in porcine pulmonary arteries and veins. Acta Physiol Scand 174:9-15.
3. Bergendorff A and Uvnäs B (1972) Storage of 5-hydroxytryptamine in rat mast cells. Evidence for an ionic binding to carboxyl groups in a granule heparin-protein complex. Acta Physiol Scand 84:320-331.
4. Björck T and Dahlén SE (1993) Leukotrienes and histamine mediate IgE-dependent contractions of human bronchi: pharmacological evidence obtained with tissues from asthmatic and non-asthmatic subjects. Pulm Pharmacol 6:87-96.
5. Coffey MJ, Phare SM, and Peters-Golden M (2000) Prolonged exposure to lipopolysaccharide inhibits macrophage 5-lipoxygenase metabolism via induction of nitric oxide synthesis. J Immunol 165:3592-3598.
6. Coffey MJ, Phare SM, and Peters-Golden M (2002) Interaction between nitric oxide, reactive oxygen intermediates and peroxynitrite in the regulation of 5-lipoxygenase metabolism. Biochim Biophys Acta 1584:81-90.
7. Coleman JW (2001) Nitric oxide in immunity and inflammation. Int Immunopharmacol 1:1397-1406.
8. Coleman JW (2002) Nitric oxide: a regulator of mast cell activation and mast cell-mediated inflammation. Clin Exp Immunol 129:4-10.
9. De Sanctis GT, MacLean JA, Hamada K, Mehta S, Scott JA, Jiao A, Yandava CN, Kobzik L, Wolyniec WW, Fabian AJ, et al. (1999) Contribution of nitric oxide synthases 1, 2 and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med 189:1621-1630.
10. Devaux Y, Seguin C, Grosjean S, de Talance N, Camaeti V, Burlet A, Zannad F, Meistelman C, Mertes PM, and Longrois D (2001) Lipopolysaccharide-induced increase of prostaglandin E(2) is mediated by inducible nitric oxide synthase activation of the constitutive cyclooxygenase and induction of membraneassociated prostaglandin E synthase. J Immunol 167:3962-3971.
11. Garvey EP, Oplinger JA, Furfine ES, Kiff RJ, Laszlo F, Whittle BJ, and Knowles RG (1997) 1400W is a slow, tight binding and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 272:4959-4963.
12. Gilchrist M, McCauley SD, and Befus AD (2004) Expression, localization and regulation of NOS in human mast cell lines: effects on leukotriene production. Blood 104:462-469.
13. Gilchrist M, Savoie M, Nohara O, Wills FL, Wallace JL, and Befus AD (2002) Nitric oxide synthase and nitric oxide production in in vivo-derived mast cells. J Leukoc Biol 71:618-624.
14. Gruetter C and Lemke S (1985) Parenchymal and vascular strips from bovine lung respond differently to vasodilators. Eur J Pharmacol 106:619-623.
15. Gustafsson LE, Leone AM, Persson MG, Wiklund NP, and Moncada S (1991) Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 181:852-857.
16. Hjoberg J, Shore S, Kobzik L, Okinaga S, Hallock A, Vallone J, Subramaniam V, De Sanctis GT, Elias JA, Drazen JM, et al. (2004) Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness. J Appl Physiol 97:249-259.
17. Lei YH, Barnes PJ, and Rogers DF (1993) Regulation of NANC neural bronchoconstriction in vivo in the guinea-pig: involvement of nitric oxide, vasoactive intestinal peptide and soluble guanylyl cyclase. Br J Pharmacol 108:228-235.
18. Manning PJ, Stevens WH, Cockcroft DW, and O'Byrne PM (1991) The role of thromboxane in allergen-induced asthmatic responses. Eur Respir J 4:667-672.
19. Masini E, Salvemini D, Pistelli A, Mannaioni PF, and Vane JR (1991) Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine. Agents Actions 33:61-63.
20. Nijkamp FP, van der Linde HJ, and Folkerts G (1993) Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro. Role of the epithelium. Am Rev Respir Dis 148:727-734.
21. Persson MG, Friberg SG, Hedqvist P, and Gustafsson LE (1993) Endogenous nitric oxide counteracts antigen-induced bronchoconstriction. Eur J Pharmacol 249:R7-R8.
22. 2: apparent correlation with in vivo modulation of mediator release. Proc Natl Acad Sci USA 85:2315-2319.
23. Ricciardolo FL, Sterk PJ, Gaston B, and Folkerts G (2004) Nitric oxide in health and disease of the respiratory system. Physiol Rev 84:731-765.
24. Roquet A, Dahlén B, Kumlin M, Ihre E, Anstren G, Binks S, and Dahlén SE (1997) Combined antagonism of leukotrienes and histamine produces predominant inhibition of allergen-induced early and late phase airway obstruction in asthmatics. Am J Respir Crit Care Med 155:1856-1863.
25. Sakata K and Bäck M (2002) Receptor preferences of cysteinyl-leukotrienes in the guinea pig lung parenchyma. Eur J Pharmacol 436:119-126.
26. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, and Needleman P (1993) Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90:7240-7244.
27. Shore PA, Burkhalter A, and Cohn VH Jr (1959) A method for the fluorometric assay of histamine in tissues. J Pharmacol Exp Ther 127:182-186.
28. Sundström E, Låstbom L, Ryrfeldt A, and Dahlén SE (2003) Interactions among three classes of mediators explain antigen-induced bronchoconstriction in the isolated perfused and ventilated guinea pig lung. J Pharmacol Exp Ther 307:408-418.
29. Swindle EJ, Metcalfe DD, and Coleman JW (2004) Rodent and human mast cells produce functionally significant intracellular reactive oxygen species but not nitric oxide. J Biol Chem 279:48751-48759.
30. Tilley SL, Coffman TM, and Koller BH (2001) Mixed messages: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J Clin Investig 108:15-23.
31. Watkins DN, Garlepp MJ, and Thompson PJ (1997) Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide. Br J Pharmacol 121:1482-1488.
32. Wikström Jonsson E and Dahlén SE (1994) Interactions between leukotrienes and histamine in the anaphylactic contraction of guinea pig lung parenchyma. J Pharmacol Exp Ther 271:615-623.
33. Wohlsen A, Martin C, Vollmer E, Branscheid D, Magnussen H, Becker WM, Lepp U, and Uhlig S (2003) The early allergic response in small airways of human precision-cut lung slices. Eur Respir J 21:1024-1032.
34. Xiong Y, Karupiah G, Hogan SP, Foster PS, and Ramsay AJ (1999) Inhibition of allergic airway inflammation in mice lacking nitric oxide synthase 2. J Immunol 162:445-452.